FAAH Inhibitor Trial for Adults With Tourette Syndrome
Phase of Trial: Phase II
Latest Information Update: 05 Nov 2018
Price : $35 *
At a glance
- Drugs PF 4457845 (Primary)
- Indications Gilles de la Tourette's syndrome
- Focus Therapeutic Use
- 25 Oct 2018 Status changed from suspended to discontinued.
- 18 Mar 2016 Status changed from recruiting to suspended due to the clinical hold placed on the study pending results from another study, according to ClinicalTrials.gov record.
- 24 Jun 2014 New trial record